Abstract
Dialysate composition is a critical aspect of the hemodialysis prescription. Despite this, trial data are almost entirely lacking to help guide the optimal dialysate composition. Often, the concentrations of key components are chosen intuitively, and dialysate composition may be determined by default based on dialysate manufacturer specifications or hemodialysis facility practices. In this review, we examine the current epidemiological evidence guiding selection of dialysate bicarbonate, calcium, magnesium, and potassium, and identify unresolved issues for which pragmatic clinical trials are needed.
© 2017 Wiley Periodicals, Inc.
MeSH terms
-
Bicarbonates / administration & dosage
-
Bicarbonates / metabolism
-
Calcium / administration & dosage
-
Calcium / metabolism
-
Dose-Response Relationship, Drug
-
Female
-
Hemodialysis Solutions / administration & dosage
-
Hemodialysis Solutions / pharmacology*
-
Humans
-
Kidney Failure, Chronic / diagnosis
-
Kidney Failure, Chronic / therapy*
-
Magnesium / administration & dosage
-
Magnesium / metabolism
-
Male
-
Monitoring, Physiologic / methods
-
Needs Assessment
-
Potassium / administration & dosage
-
Potassium / metabolism
-
Prognosis
-
Renal Dialysis / adverse effects
-
Renal Dialysis / methods*
-
Risk Assessment
-
Sodium / administration & dosage
-
Sodium / metabolism
-
Treatment Outcome
Substances
-
Bicarbonates
-
Hemodialysis Solutions
-
Sodium
-
Magnesium
-
Potassium
-
Calcium